IL23A and neoplasm: Mouse models with loss of function in both IL‐12 and IL‐23 via IL‐12/23p40 deficiency or treatment with anti–IL‐12/23p40 antibodies showed an increase,20, 21, 80 a decrease82 or no difference83 in tumor development (Table 6).